Ongoing Research Support:
U01CA294811 (MPI: Bui, Vidrine, Xangsayarath)
08/12/2024 – 07/31/2029
Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for Lao people with HIV (I-STOP).
The purpose of this research project is to compare 2 smoking cessation implementation strategies in 8 antiretroviral therapy (ART) clinics in the 5 most populous provinces/regions across Laos, using a hybrid type-2 pragmatic effectiveness-implementation study and a parallel cluster randomized trial design. Specifically, the study will compare an Ask-Advice-Connect (AAC) approach paired with an mHealth automated tobacco treatment program to an AAC approach paired with less resource intensive printed self-help material. The project has the potential to transform HIV care delivery and tobacco treatment throughout Laos to reduce tobacco-related cancers and other morbidities.
Total: $3,187,275 (Direct: $2,720,795)
OU Health Harold Hamm Diabetes Center Novel Pilot Grant (PI: Nguyen, Co-I: Bui)
07/01/2024 – 06/30/2026
Implementing A Culturally Adapted mHealth Intervention at Community Clinics.
The purpose of this mixed-methods pilot study is to assess the preliminary efficacy and implementation feasibility of our fully automated messaging program to support self-management in Vietnamese patients with diabetes in Oklahoma and Texas.
Role: Co-investigator
Total (direct): $140,000
U01 CA261598 (MPI: Bui, Vidrine)
09/17/2021 – 09/16/2026
Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT).
This research project aims to evaluate efficacy and cost-effectiveness of our theoretically and empirically based mobile health (mHealth) smoking cessation intervention for smokers living with HIV in Cambodia. This mHealth approach includes a fully automated, interactive, personalized, smartphone-delivered intervention for behavioral treatment.
Total: $3,614,445 (Direct: $2,480,787)
R33CA253600 (R21/R33) (PI: Bui)
09/01/2020 – 08/30/2026
Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Support Laos).
This research project aims to adapt and evaluate the efficacy of our theoretically and empirically based mobile health (mHealth) technology to help people quit smoking cigarettes in Lao People’s Democratic Republic.
Total: $ 1,121,290 (Direct: $ 843,863)
Completed Research Support:
GRF00005968 (PI: Nguyen, Co-I: Bui)
New Investigator Grant - Presbyterian Health Foundation
07/01/2022 – 06/30/2024
mHealth Intervention for Self-Management among Vietnamese Americans with Type 2 Diabetes (SMART-D): A Feasibility Study.
This study aims to pilot a multilevel, multicomponent, culturally tailored Vietnamese intervention project to provide diabetes education, health behavior change support, and emotional support through secure, patient-facing mobile health technology to help patients understand the disease process, gain skills to manage their condition, and adopt a healthy lifestyle.
Total (direct): $100,000
2023 PHF Research Support Award (PI: Bui)
07/03/2023 – 07/02/2024
Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Support Laos) - PHF Research Support Award.
The PHF Research Support Grant Program provides stipend support for a senior doctoral graduate student (Shweta Kulkarni) working on Dr. Bui’s externally funded research project (Support Laos) in order to accelerate the project’s progress, increase the number of publications, and position the project for continued external funding. Nested in Dr. Bui’s Support Laos project, Ms. Kulkarni’s proposed dissertation research project aims to examine the correlation between COVID-19-related stress and smoking cessation in Lao PDR.
Total: (Direct): $15,000
Oklahoma Shared Clinical & Translational Resources (OSCTR) Pilot Award (MPI: Bui, Braun)
01/17/2023 – 06/30/2024
Mobile health-based motivational interviewing to promote SARS-CoV-2 vaccination in Oklahomans (CoVacc).
This study aims to evaluate the preliminary efficacy and acceptability of our mHealth-based motivational interviewing intervention to promote SARS-CoV-2 vaccination in an Oklahoman rural population.
Total (direct): $50,000
2023 PHF Bridge Grant (PI: Bui)
10/01/2023 – 09/30/2024
Empower Patient with HPV-associated Disease to Promote HPV Vaccination (Empower) – PHF Bridge Grant component.
The purpose of the PHF Bridge Grant program is to provide funding of limited duration to OUHSC faculty members who have submitted applications (requesting >$750,000 in total direct costs) to extramural funding agencies (e.g., NIH, DoD, PCORI, or ARHQ), which have been reviewed and scored but not funded. The PHF Bridge Grant support provides a mechanism through which investigators can address scientific issues raised in peer review critiques, generate essential preliminary data, and submit more competitive revised applications. In this PHF Bridge Grant, Dr. Bui’s team plans to expand their current cervical cancer–based interactive HPV vaccination education program (IHVEP) for use by patients with oropharyngeal dysplasia or cancer, which will help to strengthen their R01 resubmission.
Total (direct): $97,666
R01CA243552 (PI: Damon Vidrine) (Co-I, Site PI: Bui)
09/01/2019 – 08/31/2024
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV.
The purpose of this randomized controlled trial is to evaluate a fully automated smartphone smoking-cessation intervention for HIV-positive smokers.
3R21CA253600-02S1 (PI: Bui)
09/01/2021 – 08/31/2022
Mobile Health Technology for Personalized Tobacco Cessation Support among Cancer Survivors in Laos (SurvLaos).
This pilot randomized controlled trial aims to adapt and evaluate the efficacy of our theoretically and empirically based mobile health (mHealth) technology to help cancer survivors and their caregivers quit smoking tobacco in Lao People’s Democratic Republic.
Total: $99,846 (Direct: $76,293)
Stephenson Cancer Center - Pilot Award (PI: Bui)
07/01/2018 – 04/30/2022
Promoting human papillomavirus vaccine uptake in high-risk adults.
This pilot study aims to determine the preliminary efficacy of an innovative, theory-based approach that combines partner referral and peer-driven intervention to increase human papillomavirus vaccine uptake in eligible high-risk adults in Oklahoma City, OK, USA.
Total: $40,000 (Direct: $40,000)
NCORP-Gogoi-GY7, NRG Oncology - NCI Community Oncology Research Program (NCORP) Pilot Award (PI: Gogoi, Radhika)
01/15/2021 – 06/30/2022
Relational Agents in HPV Vaccine Education.
This project aims to explore the efficacy of a computerized simulated interactable healthcare provider in educating survivors of an HPV related disease (e.g., cervical cancer) about the importance of HPV vaccination and engaging them in promoting HPV vaccination. Study sites include the NCI-designated Stephenson Cancer Center at the University of Oklahoma Health Sciences Center and the Karmanos Cancer Institute (KCI) at Wayne State University.
Role: Co-investigator, Site PI
NCI SBIR PHS 2021-1 (PI: Amarasingham)
09/16/2021 – 06/15/2022
Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population.
The goal of this project is to design and launch an Information Technology (IT) platform that enables easy incorporation of Social Determinants of Health data into cancer patients’ electronic health records in order to improve coordination of care for cancer patients in multiple cancer centers across the US.
Role: Co-investigator
Presbyterian Health Foundation - Seed Grant (PI: Bui)
07/01/2018 – 06/30/2020
Using partner referral to increase human papillomavirus vaccine uptake.
The purpose of this mixed-methods pilot study is to determine the feasibility of an innovative, evidence-based approach—partner referral—to increase HPV vaccine uptake in people living with HIV in Oklahoma City, OK, USA.